GPT and Insulin resistance: A meta-analysis of 7 trials treating patients with MASLD using dapagliflozin 10 mg showed that serum AST and ALT values decreased, insulin resistance (HOMA-IR) improved, no decreases in gamma-glutamyl transferase (GGT) were noted, and total serum cholesterol increased.